← back to search

G.J. Correy

University of California, San Francisco · US
Area of research
Materials Chemistry · Physical and Theoretical Chemistry
Research interest
Research interests include Machine Learning in Materials Science, thermodynamics and calorimetric analyses, X-ray Diffraction in Crystallography, and Mass Spectrometry Techniques and Applications.
h-index
14
citations
1,282
works
203
NIH funding
primary concept
email

Recent publications

Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning
Science Advances 2025cited by 18position: firstdoi
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M <sup>Pro</sup> inhibitors with potent in vivo efficacy
Science Advances 2025cited by 12position: middledoi
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2
eLife 2025cited by 6position: middledoi
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 5position: middledoi
Structural characterization of ligand binding and pH-specific enzymatic activity of mouse Acidic Mammalian Chitinase
eLife 2024cited by 6position: middledoi
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
Proceedings of the National Academy of Sciences 2023cited by 128position: middledoi
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo
PLoS Pathogens 2023cited by 35position: middledoi
Structural characterization of ligand binding and pH-specific enzymatic activity of mouse Acidic Mammalian Chitinase
eLife 2023cited by 5position: middledoi
The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature
Science Advances 2022cited by 51position: firstdoi
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
Science Advances 2021cited by 206position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

James S. Fraser · University of California, San Francisco6 papers (2022–2025)Alan Ashworth · UCSF Helen Diller Family Comprehensive Cancer Center4 papers (2022–2025)Adam R. Renslo · University of California, San Francisco3 papers (2023–2025)Michael C. Thompson · University of California, Berkeley3 papers (2022–2024)Moira Rachman · University of California, San Francisco3 papers (2023–2025)Brian K. Shoichet · Quantitative BioSciences3 papers (2023–2025)Morgan E. Diolaiti · University of California, San Francisco3 papers (2023–2025)Stefan Gahbauer · University of California, San Francisco3 papers (2022–2025)Yagmur U. Doruk · University of California, San Francisco3 papers (2023–2025)Takaya Togo · University of California, San Francisco2 papers (2025–2025)Dmytro S. Radchenko · Enamine (Ukraine)2 papers (2023–2025)Steven J. Van Dyken · Washington University in St. Louis2 papers (2023–2024)Andrew K. Ecker · Scripps Research Institute2 papers (2023–2024)R. Jeffrey Neitz · University of California, San Francisco2 papers (2023–2025)Richard M. Locksley · Howard Hughes Medical Institute2 papers (2023–2024)Ian B. Seiple · Scripps Research Institute2 papers (2023–2024)Bryan Faust · University of California, San Francisco2 papers (2023–2024)Priyadarshini Jaishankar · University of California, San Francisco2 papers (2025–2025)Roberto Efraín Díaz · University of California, San Francisco2 papers (2023–2024)Yurii S. Moroz · John Wiley & Sons (United States)2 papers (2023–2025)